Your browser doesn't support javascript.
loading
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic.
Bayle, Arnaud; Baldini, Capucine; Martin-Romano, Patricia; Michot, Jean-Marie; Champiat, Stéphane; Bahleda, Rastilav; Gazzah, Anas; Marabelle, Aurélien; Verlingue, Loic; Geraud, Arthur; Morel, Daphné; Michiels, Stefan; Hollebecque, Antoine; Albiges, Laurence; Besse, Benjamin; Soria, Jean-Charles; Massard, Christophe; Barlesi, Fabrice; Postel-Vinay, Sophie.
Afiliación
  • Bayle A; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris, France; Oncostat U1018, Inserm, Paris-Saclay University, Labeled Ligue Contre le Cancer, Villejuif, France. Electronic a
  • Baldini C; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Martin-Romano P; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Michot JM; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Champiat S; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Bahleda R; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Gazzah A; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Marabelle A; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Verlingue L; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Geraud A; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Morel D; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Michiels S; Oncostat U1018, Inserm, Paris-Saclay University, Labeled Ligue Contre le Cancer, Villejuif, France; Biostatistics and Epidemiology Office, Gustave Roussy, Villejuif Cedex, France.
  • Hollebecque A; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Albiges L; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Besse B; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Soria JC; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris, France.
  • Massard C; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France; Université Paris Saclay, Université Paris-Sud, Faculté de Médicine, Le Kremlin Bicêtre, Paris, France.
  • Barlesi F; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.
  • Postel-Vinay S; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France; ATIP-Avenir, U981 INSERM, Villejuif, France. Electronic address: sophie.postel-vinay@gustaveroussy.fr.
Cancer Cell ; 39(8): 1039-1041, 2021 08 09.
Article en En | MEDLINE | ID: mdl-34197735
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / SARS-CoV-2 / COVID-19 / Hospitales / Oncología Médica / Neoplasias Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / SARS-CoV-2 / COVID-19 / Hospitales / Oncología Médica / Neoplasias Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article